Skip to main content

Table 4 Analysis of tumour volumes detected via 7 T in vivo MRI in a CT1258 based in vivo model of prostate cancer

From: Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer

Animal

Day 17;

Day 22;

Day 24;

Day 25;

Day 39;

Day 43;

Day 53;

Day 59;

Day 66;

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

5

 

7.26

13.42

      

(♂, intact)

         

6

 

0.531

11.78

  

699.19

   

(♂, intact)

         

7

   

1.37

1.51

 

2.14

11.43

36.50

(♂, intact)

         

8

1.65

11.27

24.72

  

1,928.83

   

(♂, castrated)

         

9

 

8.66

32.42

  

1,533.26

   

(♂, castrated)

         
  1. The male animals received 103 MnCl2 labelled cells. The tumour volumes are displayed for the respective days of MRI measurements after subcutaneous injection.
  2. ♂ = male animal.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us